Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

309
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
309

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor unit behavior adaptations across lifespan: sex differences in young, middle-aged and old adults.

npj aging·2026
Same author

Geriatric team support in the emergency department-a randomised trial investigating the effects on hospital admission and community care in older adults (GerED-21).

Age and ageing·2026
Same author

Clinical Trajectories of Neurodegenerative Diseases in Older Adults: A Three-Sphere Framework for Precision Geriatric Neurology.

Life (Basel, Switzerland)·2026
Same author

Multidisciplinary Approach to Ventricular Arrhythmias in the CICU: Integrating Mechanical Circulatory Support, Ablation, and Emerging Therapies.

Journal of clinical medicine·2026
Same author

Exercise-Based Cardiac Rehabilitation for Peripheral Artery Disease.

Journal of clinical medicine·2026
Same author

Current use and practices of lung ultrasound in geriatric care: insights from a national survey.

Aging clinical and experimental research·2026

Related Experiment Video

Updated: Jun 25, 2025

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

12.5K

Dopamine Pharmacodynamics: New Insights.

Fulvio Lauretani1,2, Francesco Giallauria3, Crescenzo Testa1

  • 1Geriatric Clinic Unit, Geriatric-Rehabilitation Department, University Hospital, 43126 Parma, Italy.

International Journal of Molecular Sciences
|May 25, 2024
PubMed
Summary

Dopamine, a crucial neurotransmitter, influences motor control and reward. Its dysfunction is linked to diseases and addiction, highlighting its role in neuromodulation and potential neurodegeneration.

Keywords:
addictiondopamineneuromodulationneurotoxicityreward system

More Related Videos

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.9K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.8K

Related Experiment Videos

Last Updated: Jun 25, 2025

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

12.5K
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.9K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.8K

Area of Science:

  • Neuroscience
  • Neurobiology
  • Neuropharmacology

Background:

  • Dopamine is a vital neurotransmitter regulating motor control, motivation, reward, cognition, and reproductive functions.
  • Dysregulation of the dopaminergic system is implicated in numerous human diseases.
  • Dopamine plays a critical role in compulsive behaviors, reward pathways, and addiction.

Purpose of the Study:

  • To present dopamine as a model for both neurotransmission and neuromodulation.
  • To explore how substance abuse alters neuronal architecture and function.
  • To elucidate the progression from maladaptive neuromodulation to neurodegeneration.

Main Methods:

  • Review of existing literature on dopamine's role in physiological and pathological processes.
  • Analysis of the impact of substance abuse on dopaminergic pathways.
  • Examination of the mechanisms underlying synaptic plasticity and morphological changes.

Main Results:

  • Substance abuse, including methamphetamine, cocaine, and alcohol, induces lasting changes in neuronal activity.
  • These changes result in synaptic plasticity, leading to morphological and functional alterations.
  • The process progresses from maladaptive neuromodulation to potential neurodegeneration.

Conclusions:

  • Dopamine's dual role as a neurotransmitter and neuromodulator is central to understanding brain function and disease.
  • Substance abuse triggers a cascade of neurobiological changes, impacting neuronal structure and function.
  • Understanding these dopamine-mediated changes is crucial for developing therapeutic strategies for addiction and related neurological disorders.